BioWorld Today is the newspaper of record for the biotechnology industry. Delivered every business day to leading biotechnology professionals and investors, BioWorld Today helps bring about success in the business of biotech. Each edition of this high-speed intelligence service covers the wide range of issues that are having a dramatic impact on the future of biotechnology. Topics include scientific milestones, capital sources and venture capital financing, corporate financial and stock performance, strategic alliances, agreements, sales and mergers, and FDA and congressional actions. Available via fax, online, and e-mail.
250 issues online, faxed, or e-mailed by 8 a.m. each business day.